Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children

Author： Lee Mee   Ra Young   Park Jun   Goo Hyun   Ahn Seung   Khang Shin   Song Joon   Kim Yoon   Ghim Thad  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.80, Iss.3, 2006-12, pp. : 277-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy*

By Escobar P.F.   Lurain J.R.   Singh D.K.   Bozorgi K.   Fishman D.A.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 552-557

Elsevier

Access to resources Recommend Favorite

Nitrosourea-based chemotherapy for low grade gliomas failing initial treatment with temozolomide

By Kaloshi Gentian   Sierra del Rio Monica   Ducray François   Psimaras Dimitri   Idbaih Ahmed   Laigle-Donadey Florence   Taillibert Sophie   Houillier Caroline   Dehais Caroline   Omuro Antonio   Sanson Marc   Delattre Jean-Yves   Hoang-Xuan Khe  

Journal of Neuro-Oncology, Vol. 100, Iss. 3, 2010-12 ,pp. : 439-441

Springer Publishing Company

Access to resources Recommend Favorite

Upfront chemotherapy with CCNU alone for adults’ low-grade gliomas: a clinical analysis

By Kaloshi Gentian   Rroji Arben   Petrela Mentor  

Journal of Neuro-Oncology, Vol. 117, Iss. 2, 2014-04 ,pp. : 373-374

Springer Publishing Company

Access to resources Recommend Favorite

Cognitive functions in low-grade gliomas: disease and treatment effects

By Correa Denise   DeAngelis Lisa   Shi Weiji   Thaler Howard   Lin Michael   Abrey Lauren  

Journal of Neuro-Oncology, Vol. 81, Iss. 2, 2007-01 ,pp. : 175-184

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Advanced or Recurrent Endometrial Carcinoma with Combination of Etoposide, Cisplatin, and 5-Fluorouracil: A Phase II Study

By Pierga J.Y.   Dieras V.   Paraiso D.   Dorval T.   Palangie T.   Beuzeboc P.   Jouve M.   Scholl S.M.   Garcia-Giralt E.   Pouillart P.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 59-63

Academic Press

Access to resources Recommend Favorite